←Back to Expert Scholars
Translational Medicine / 转化医学Theranostics, PSMA and DOTATATE
Lisa Bodei
MD, PhD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Director of Targeted Radionuclide Therapy
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lisa Bodei is a nuclear medicine physician specializing in peptide receptor radionuclide therapy for neuroendocrine tumors. She contributed to the NETTER-1 trial of 177Lu-DOTATATE and leads theranostic practice at MSK. Her work advances dosimetry-guided radionuclide therapy.
Share:
🧪Research Fields 研究领域
DOTATATE Lu-177 therapy
NETTER-1
neuroendocrine tumors
dosimetry
theranostics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lisa Bodei 的研究动态
Follow Lisa Bodei's research updates
留下邮箱，当我们发布与 Lisa Bodei（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment